We want to contribute to the debate to help regulators address the key issues facing the industry
We have always been clear that we support regulation that is based on robust evidence and thorough research, respects legal rights and livelihoods and delivers on the intended policy aims, while recognising unintended consequences.
Along with the industry, governments and the public health community have a key role to play in maximising the potential for reduced-risk products (RRPs) to contribute to harm reduction. For these products to be a success, they must be supported by effective regulatory and policy regimes that enable responsible growth and promote informed consumer choice. This must then be complemented by responsible practices by the industry.
Our experience and expertise mean that we have much to offer to governments and regulators when it comes to helping develop policies.
We believe that when new regulations are being developed, decisions need to be based on thorough research and open consultation with those likely to be affected, including the tobacco industry.
We would like to see effective, evidence-based regulation that meets public-health objectives but does not impede our ability to compete, respects our legal rights and does not damage retailers.
For more information about BAT’s view on Regulation, please visit our Global website: British American Tobacco - Regulation